Long-term all-cause mortality and cardiovascular outcomes in Scottish children after initiation of renal replacement therapy: A national cohort study
Pediatric Nephrology Mar 10, 2020
Galiyeva DB, Jackson CA, Wild SH, et al. - Researchers utilized data from the Scottish Renal Registry for children who started renal replacement therapy (RRT) between 1961 and 2013, to assess long-term survival as well as the incidence of fatal and nonfatal cardiovascular disease (CVD) events and determinants of these consequences in this pediatric patient population. The analysis involved 477 children; 55% were boys; congenital urinary tract disease (CAKUT) was present in almost 50%; a transplant as the first mode of RRT was received by 10%. An incident of CVD event was reported in 20.9% of the 381 patients with morbidity data available, during a median observation period of 14.96 years. Factors related to a higher risk of all-cause mortality included age < 2 years at the initiation of RRT, receiving dialysis rather than a kidney transplant and primary renal disease (PRD) other than CAKUT or glomerulonephritis (GN). A higher risk of CVD incidence was noted in relation to factors such as male gender, receiving dialysis rather than a kidney transplant and PRD other than CAKUT or GN. Findings revealed high mortality as well as CVD incidence in children receiving RRT. Increased risk of both all-cause mortality and CVD incidence was observed in correlation with PRD and RRT modality.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries